Replimune Group Inc logo

Replimune Group Inc

NAS:REPL (USA)  
$ 8.23 +0.28 (+3.52%) 10:08 PM EST
At Loss
P/B:
1.20
Market Cap:
$ 505.22M
Enterprise V:
$ 114.68M
Volume:
480.62K
Avg Vol (2M):
1.61M
Also Trade In:
Volume:
480.62K
At Loss
Avg Vol (2M):
1.61M

Business Description

Description
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
Name Current Vs Industry Vs History
Cash-To-Debt 6.15
Equity-to-Asset 0.79
Debt-to-Equity 0.18
Debt-to-EBITDA -0.38
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 74.13
9-Day RSI 62.22
14-Day RSI 55.89
6-1 Month Momentum % -62.1
12-1 Month Momentum % -64.78

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.4
Quick Ratio 12.4
Cash Ratio 12.07

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.6
Shareholder Yield % -4.92

Financials (Next Earnings Date:2024-05-17 Est.)

REPL's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:REPL

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Replimune Group Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -3.16
Beta 0.18
Volatility % 50.39
14-Day RSI 55.89
14-Day ATR ($) 0.501483
20-Day SMA ($) 7.65575
12-1 Month Momentum % -64.78
52-Week Range ($) 5.89 - 24.81
Shares Outstanding (Mil) 61.39

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Replimune Group Inc Filings

Filing Date Document Date Form
No Filing Data

Replimune Group Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Replimune Group Inc Frequently Asked Questions

What is Replimune Group Inc(REPL)'s stock price today?
The current price of REPL is $8.23. The 52 week high of REPL is $24.81 and 52 week low is $5.89.
When is next earnings date of Replimune Group Inc(REPL)?
The next earnings date of Replimune Group Inc(REPL) is 2024-05-17 Est..
Does Replimune Group Inc(REPL) pay dividends? If so, how much?
Replimune Group Inc(REPL) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1